Nova Leap Health Corp.
NLH.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 26.55% | 10.33% | 0.52% | -2.25% | -5.08% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 26.55% | 10.33% | 0.52% | -2.25% | -5.08% |
| Cost of Revenue | 22.92% | 8.53% | 1.72% | -3.23% | -7.47% |
| Gross Profit | 32.36% | 13.25% | -1.30% | -0.60% | -0.97% |
| SG&A Expenses | 30.03% | 18.46% | 4.95% | 2.17% | -1.77% |
| Depreciation & Amortization | 50.40% | 30.94% | -21.77% | -28.54% | -45.91% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.94% | 12.42% | 2.09% | -2.31% | -7.16% |
| Operating Income | 41.46% | -59.72% | -30.42% | -0.19% | 112.25% |
| Income Before Tax | -281.58% | -113.65% | 189.29% | -129.93% | 215.02% |
| Income Tax Expenses | -203.17% | -97.94% | 176.06% | -47.55% | 197.97% |
| Earnings from Continuing Operations | -313.22% | -116.55% | 192.84% | -154.65% | 223.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -313.22% | -116.55% | 192.84% | -154.65% | 223.71% |
| EBIT | 41.46% | -59.72% | -30.42% | -0.19% | 112.25% |
| EBITDA | 44.67% | -19.32% | -35.61% | -14.23% | 3.51% |
| EPS Basic | -311.54% | -116.67% | 192.79% | -154.55% | 223.81% |
| Normalized Basic EPS | -244.44% | -105.26% | 2,200.00% | -105.71% | 242.11% |
| EPS Diluted | -311.54% | -120.00% | 190.09% | -160.00% | 223.81% |
| Normalized Diluted EPS | -244.44% | -105.26% | 2,200.00% | -105.71% | 242.11% |
| Average Basic Shares Outstanding | -0.24% | -0.03% | 0.17% | 0.00% | 1.53% |
| Average Diluted Shares Outstanding | -0.24% | -0.03% | 0.17% | 0.31% | 1.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |